NEU 6.41% $15.27 neuren pharmaceuticals limited

Phelan-McDermid Syndrome, page-86

  1. 592 Posts.
    lightbulb Created with Sketch. 315
    I would be very happy if there was a buyback, it would be a very positive signal for the market which would lead Neuren to be increasingly armored while waiting for an indispensable offer that will arrive within a year
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.